We use cookies to ensure that we give you the best experience on our website. By continuing to use our site, you are agreeing to our use of cookies. You can change your cookie settings at any time if you want. Find out more in our privacy and cookies policy.
In this section
Watch all the content you missed at the 2019 UK Cystic Fibrosis Conference. We have also answered some of the questions posed on our online tool Slido that our presenters didn't have time to answer on the day!
09 October 2019
David Ramsden, Chief Executive, and Dr Janet Allen, Director of Strategic Innovation, welcome delegates to the 2019 UK Cystic Fibrosis Conference.
10 October 2019
Dr Mike Gray - New therapies for cystic fibrosis are under development, and some of these therapies may improve the way existing precision medicines work or cause them to work in a novel and different way. In this session we’ll hear from two companies with different approaches, including therapies that may work for anyone irrespective of their genotype.
Professor Martin Gosling PhD, Chief Scientific Officer, Enterprise Therapeutics
Dr Marija Zecevic, Proteostasis
Professor Andres Floto (Royal Papworth Hospital) and Sammie Read
Professor Jane Davies and Dr Claire Edmondson (Royal Brompton Hospital) and Uisdean McKenzie
John Winn, Microsoft Research Institute, Cambridge
Kirsty Hill (Magic Bullet) and Mark Edwards
Q&A panel discussion
Professor Pietro Cicuta, University of Cambridge
Dr Darius Armstrong-James, Imperial College London
Dr Martin Welch, University of Cambridge
Jessica Lee and Dr Paula Sommer
Dr Lisa Strug, Sick Kids Toronto
Professor Andres Floto
Oli Lewington, Director of Marketing and Communications at the Cystic Fibrosis Trust
Members of the Trust’s research team reflect on day one of UKCFC, providing updates on: the development of new therapies for cystic fibrosis, innovative ways to reduce the burden of care, Trust-funded research and personalised medicines of the future.
A virtual conversation between two people with CF about their lived experience of and concerns about getting older with cystic fibrosis and all the challenges, concerns and happiness it brings.
Michèle Puckey, Paediatric Clinical Psychologist, Royal Brompton Hospital, discusses the psychological impact of the potential for transformation treatments to change the future of cystic fibrosis.
Highlighting the collaborative relationship between supporters and the Cystic Fibrosis Trust and showing the impact their dedication has on the Trust’s ability to do the work it does.
Richard Hunt CBE, Cystic Fibrosis Trust Chairman
Led by Dr Mandy Bryon, Consultant Clinical Psychologist and Head of Psychological Services, Great Ormond Street Hospital and Helen Oxley, Consultant Clinical Psychologist, Manchester Adult Cystic Fibrosis Centre. Facilitated by Michèle Puckey, Royal Brompton Hospital and Dr Samantha Phillips, Bristol Children’s Hospital.
Led by Elaine Bowman Specialist pharmacist, respiratory medicine, Royal Brompton and Harefield NHS Trust and Michael Dooney, CF pharmacist, Blackpool Adult CF Service and Manchester Adult CF Centre.
We fund research to tackle some of the most pressing issues in CF today. Find out how your donations are making a difference.
Cystic fibrosis, or CF, affects the lungs, digestive system and other organs, and there are around 10,500 people living with it in the UK.
Get in touch with us to speak to someone on our Helpline, find out about an event or speak to our Press Team.